{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:25:17Z","timestamp":1779161117013,"version":"3.51.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R21HD089053"],"award-info":[{"award-number":["R21HD089053"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA245067"],"award-info":[{"award-number":["R21 CA245067"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM073646"],"award-info":[{"award-number":["R01GM073646"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Persons with Down syndrome (DS, trisomy 21) have widespread cellular protein trafficking defects. There is a paucity of data describing the intracellular transport of IgG in the context of endosomal-lysosomal alterations linked to trisomy 21. In this study, we analyzed the intracellular traffic of IgG mediated by the human neonatal Fc receptor (FcRn) in fibroblast cell lines with trisomy 21. Intracellular IgG trafficking studies in live cells showed that fibroblasts with trisomy 21 exhibit higher proportion of IgG in lysosomes (~\u200910% increase), decreased IgG content in intracellular vesicles (~\u20099% decrease), and a trend towards decreased IgG recycling (~\u200955% decrease) in comparison to diploid cells. Amyloid-beta precursor protein (APP) overexpression in diploid fibroblasts replicated the increase in IgG sorting to the degradative pathway observed in cells with trisomy 21. The impact of\n                    <jats:italic>APP<\/jats:italic>\n                    on the expression of\n                    <jats:italic>FCGRT<\/jats:italic>\n                    (alpha chain component of FcRn) was investigated by\n                    <jats:italic>APP<\/jats:italic>\n                    knock down and overexpression of the APP protein.\n                    <jats:italic>APP<\/jats:italic>\n                    knock down increased the expression of\n                    <jats:italic>FCGRT<\/jats:italic>\n                    mRNA by\u2009~\u200960% in both diploid and trisomic cells. Overexpression of APP in diploid fibroblasts and HepG2 cells resulted in a decrease in\n                    <jats:italic>FCGRT<\/jats:italic>\n                    and FcRn expression. Our results indicate that the intracellular traffic of IgG is altered in cells with trisomy 21. This study lays the foundation for future investigations into the role of FcRn in the context of DS.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-90469-z","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T06:04:00Z","timestamp":1622009040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of the intracellular traffic of IgG in the context of Down syndrome (trisomy 21)"],"prefix":"10.1038","volume":"11","author":[{"given":"R. B.","family":"Cejas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tama\u00f1o-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"90469_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gim.2016.127","volume":"19","author":"G de Graaf","year":"2017","unstructured":"de Graaf, G., Buckley, F. & Skotko, B. G. Estimation of the number of people with Down syndrome in the United States. Genet. Med. 19, 439\u2013447. https:\/\/doi.org\/10.1038\/gim.2016.127 (2017).","journal-title":"Genet. Med."},{"key":"90469_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","volume":"17","author":"AH Bittles","year":"2007","unstructured":"Bittles, A. H., Bower, C., Hussain, R. & Glasson, E. J. The four ages of Down syndrome. Eur. J. Pub. Health 17, 221\u2013225. https:\/\/doi.org\/10.1093\/eurpub\/ckl103 (2007).","journal-title":"Eur. J. Pub. Health"},{"key":"90469_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/GIM.0b013e3181634867","volume":"10","author":"SB Freeman","year":"2008","unstructured":"Freeman, S. B. et al. Ethnicity, sex, and the incidence of congenital heart defects: A report from the National Down Syndrome Project. Genet. Med. 10, 173\u2013180. https:\/\/doi.org\/10.1097\/GIM.0b013e3181634867 (2008).","journal-title":"Genet. Med."},{"key":"90469_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ymgme.2011.03.018","volume":"104","author":"LL McCabe","year":"2011","unstructured":"McCabe, L. L. & McCabe, E. R. Down syndrome: Issues to consider in a national registry, research database and biobank. Mol. Genet. Metab. 104, 10\u201312. https:\/\/doi.org\/10.1016\/j.ymgme.2011.03.018 (2011).","journal-title":"Mol. Genet. Metab."},{"key":"90469_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ejmg.2015.11.003","volume":"58","author":"C Stoll","year":"2015","unstructured":"Stoll, C., Dott, B., Alembik, Y. & Roth, M. P. Associated congenital anomalies among cases with Down syndrome. Eur. J. Med. Genet. 58, 674\u2013680. https:\/\/doi.org\/10.1016\/j.ejmg.2015.11.003 (2015).","journal-title":"Eur. J. Med. Genet."},{"key":"90469_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/phar.1880","volume":"37","author":"E Hefti","year":"2017","unstructured":"Hefti, E. & Blanco, J. G. Pharmacotherapeutic considerations for individuals with Down syndrome. Pharmacotherapy 37, 214\u2013220. https:\/\/doi.org\/10.1002\/phar.1880 (2017).","journal-title":"Pharmacotherapy"},{"key":"90469_CR7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jaci.2014.07.015","volume":"134","author":"RHJ Verstegen","year":"2014","unstructured":"Verstegen, R. H. J. et al. Defective B-cell memory in patients with Down syndrome. J. Allergy Clin. Immunol. 134, 1346-1353.e1349. https:\/\/doi.org\/10.1016\/j.jaci.2014.07.015 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"90469_CR8","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1590\/s0100-879x2006001200010","volume":"39","author":"BT Costa-Carvalho","year":"2006","unstructured":"Costa-Carvalho, B. T. et al. Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz. J. Med. Biol. Res. 39, 1587\u20131592. https:\/\/doi.org\/10.1590\/s0100-879x2006001200010 (2006).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"90469_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0301-0546(02)79091-5","volume":"30","author":"C Barradas","year":"2002","unstructured":"Barradas, C. et al. IgG subclasses serum concentrations in a population of children with Down syndrome: Comparative study with siblings and general population. Allergol. Immunopathol. 30, 57\u201361. https:\/\/doi.org\/10.1016\/s0301-0546(02)79091-5 (2002).","journal-title":"Allergol. Immunopathol."},{"key":"90469_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ajmg.1320370746","volume":"7","author":"MA Avanzini","year":"1990","unstructured":"Avanzini, M. A. et al. Humoral immunodeficiencies in Down syndrome: Serum IgG subclass and antibody response to hepatitis B vaccine. Am. J. Med. Genet. Suppl. 7, 231\u2013233. https:\/\/doi.org\/10.1002\/ajmg.1320370746 (1990).","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"90469_CR11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0225","author":"AA Beckhaus","year":"2018","unstructured":"Beckhaus, A. A. & Castro-Rodriguez, J. A. Down syndrome and The Risk Of Severe RSV infection: A meta-analysis. Pediatrics https:\/\/doi.org\/10.1542\/peds.2018-0225 (2018).","journal-title":"Pediatrics"},{"key":"90469_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00431-018-3142-x","volume":"177","author":"A Simon","year":"2018","unstructured":"Simon, A., Gehrmann, S., Wagenpfeil, G. & Wagenpfeil, S. Palivizumab use in infants with Down syndrome-report from the German Synagis Registry 2009\u20132016. Eur. J. Pediatr. 177, 903\u2013911. https:\/\/doi.org\/10.1007\/s00431-018-3142-x (2018).","journal-title":"Eur. J. Pediatr."},{"key":"90469_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40272-017-0264-y","volume":"20","author":"T Kashiwagi","year":"2018","unstructured":"Kashiwagi, T., Okada, Y. & Nomoto, K. Palivizumab prophylaxis against respiratory syncytial virus infection in children with immunocompromised conditions or Down syndrome: A multicenter, post-marketing surveillance in Japan. Paediatr Drugs 20, 97\u2013104. https:\/\/doi.org\/10.1007\/s40272-017-0264-y (2018).","journal-title":"Paediatr Drugs"},{"key":"90469_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1136\/archdischild-2018-316408","volume":"104","author":"B Paes","year":"2019","unstructured":"Paes, B. & Mitra, S. Palivizumab for children with Down syndrome: Is the time right for a universal recommendation? Arch. Dis. Child 104, 719\u2013721. https:\/\/doi.org\/10.1136\/archdischild-2018-316408 (2019).","journal-title":"Arch. Dis. Child"},{"key":"90469_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/archdischild-2018-316140","volume":"104","author":"D Huggard","year":"2019","unstructured":"Huggard, D. & Molloy, E. J. Question 1: Palivizumab for all children with Down syndrome? Arch. Dis. Child 104, 94\u201397. https:\/\/doi.org\/10.1136\/archdischild-2018-316140 (2019).","journal-title":"Arch. Dis. Child"},{"key":"90469_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ymgme.2012.07.011","volume":"107","author":"L Seewald","year":"2012","unstructured":"Seewald, L., Taub, J. W., Maloney, K. W. & McCabe, E. R. Acute leukemias in children with Down syndrome. Mol. Genet. Metab. 107, 25\u201330. https:\/\/doi.org\/10.1016\/j.ymgme.2012.07.011 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"90469_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-015-9307-1","author":"E Hefti","year":"2015","unstructured":"Hefti, E. & Blanco, J. Anthracycline-related cardiotoxicity in patients with acute myeloid leukemia and Down syndrome: A literature review. Cardiovasc. Toxicol. https:\/\/doi.org\/10.1007\/s12012-015-9307-1 (2015).","journal-title":"Cardiovasc. Toxicol."},{"key":"90469_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/mph.0000000000000540","volume":"38","author":"E Hefti","year":"2016","unstructured":"Hefti, E. & Blanco, J. G. Pharmacokinetics of chemotherapeutic drugs in pediatric patients with Down syndrome and leukemia. J. Pediatr. Hematol. Oncol. 38, 283\u2013287. https:\/\/doi.org\/10.1097\/mph.0000000000000540 (2016).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"90469_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1172\/JCI6968","volume":"104","author":"BL Dickinson","year":"1999","unstructured":"Dickinson, B. L. et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J. Clin. Investig. 104, 903\u2013911. https:\/\/doi.org\/10.1172\/JCI6968 (1999).","journal-title":"J. Clin. Investig."},{"key":"90469_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0198-8859(00)00244-5","volume":"62","author":"F Antohe","year":"2001","unstructured":"Antohe, F., Radulescu, L., Gafencu, A., Ghetie, V. & Simionescu, M. Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum. Immunol. 62, 93\u2013105 (2001).","journal-title":"Hum. Immunol."},{"key":"90469_CR21","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.4049\/jimmunol.172.4.2021","volume":"172","author":"RJ Ober","year":"2004","unstructured":"Ober, R. J., Martinez, C., Vaccaro, C., Zhou, J. & Ward, E. S. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J. Immunol. 172, 2021\u20132029 (2004).","journal-title":"J. Immunol."},{"key":"90469_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.it.2006.05.004","volume":"27","author":"CL Anderson","year":"2006","unstructured":"Anderson, C. L. et al. Perspective\u2013FcRn transports albumin: Relevance to immunology and medicine. Trends Immunol. 27, 343\u2013348. https:\/\/doi.org\/10.1016\/j.it.2006.05.004 (2006).","journal-title":"Trends Immunol."},{"key":"90469_CR23","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1074\/jbc.M114.603712","volume":"290","author":"MJ Borrok","year":"2015","unstructured":"Borrok, M. J. et al. pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling. J. Biol. Chem. 290, 4282\u20134290. https:\/\/doi.org\/10.1074\/jbc.M114.603712 (2015).","journal-title":"J. Biol. Chem."},{"key":"90469_CR24","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3389\/fimmu.2019.01540","volume":"10","author":"M Pyzik","year":"2019","unstructured":"Pyzik, M. et al. The neonatal Fc receptor (FcRn): A misnomer?. Front. Immunol. 10, 1540. https:\/\/doi.org\/10.3389\/fimmu.2019.01540 (2019).","journal-title":"Front. Immunol."},{"issue":"Suppl 1","key":"90469_CR25","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1007\/s10875-012-9768-y","volume":"33","author":"T Rath","year":"2013","unstructured":"Rath, T. et al. The immunologic functions of the neonatal Fc receptor for IgG. J. Clin. Immunol. 33(Suppl 1), S9-17. https:\/\/doi.org\/10.1007\/s10875-012-9768-y (2013).","journal-title":"J. Clin. Immunol."},{"key":"90469_CR26","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1182\/blood.2019001133","volume":"135","author":"DB Cines","year":"2020","unstructured":"Cines, D. B. et al. FcRn augments induction of tissue factor activity by IgG-containing immune complexes. Blood 135, 2085\u20132093. https:\/\/doi.org\/10.1182\/blood.2019001133 (2020).","journal-title":"Blood"},{"key":"90469_CR27","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1073\/pnas.0908953107","volume":"107","author":"Y Jiang","year":"2010","unstructured":"Jiang, Y. et al. Alzheimer\u2019s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc. Natl. Acad. Sci. USA 107, 1630\u20131635. https:\/\/doi.org\/10.1073\/pnas.0908953107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"90469_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2017.10.001","volume":"114","author":"DJ Colacurcio","year":"2018","unstructured":"Colacurcio, D. J., Pensalfini, A., Jiang, Y. & Nixon, R. A. Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer\u2019s Disease. Free Radic. Biol. Med. 114, 40\u201351. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.10.001 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"90469_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/mp.2015.97","volume":"21","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. Evidence that the rab5 effector APPL1 mediates APP-betaCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer\u2019s disease. Mol. Psychiatry 21, 707\u2013716. https:\/\/doi.org\/10.1038\/mp.2015.97 (2016).","journal-title":"Mol. Psychiatry"},{"key":"90469_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41467-018-03061-x","volume":"9","author":"A Grevys","year":"2018","unstructured":"Grevys, A. et al. A human endothelial cell-based recycling assay for screening of FcRn targeted molecules. Nat. Commun. 9, 621. https:\/\/doi.org\/10.1038\/s41467-018-03061-x (2018).","journal-title":"Nat. Commun."},{"key":"90469_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019 (2012).","journal-title":"Nat. Methods"},{"key":"90469_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ymeth.2017.01.005","volume":"115","author":"JA Pike","year":"2017","unstructured":"Pike, J. A., Styles, I. B., Rappoport, J. Z. & Heath, J. K. Quantifying receptor trafficking and colocalization with confocal microscopy. Methods 115, 42\u201354. https:\/\/doi.org\/10.1016\/j.ymeth.2017.01.005 (2017).","journal-title":"Methods"},{"key":"90469_CR33","doi-asserted-by":"publisher","first-page":"W104","DOI":"10.1093\/nar\/gkn250","volume":"36","author":"ZJ Lu","year":"2008","unstructured":"Lu, Z. J. & Mathews, D. H. OligoWalk: An online siRNA design tool utilizing hybridization thermodynamics. Nucleic Acids Res. 36, W104-108. https:\/\/doi.org\/10.1093\/nar\/gkn250 (2008).","journal-title":"Nucleic Acids Res."},{"key":"90469_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","volume":"6","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis, S. E. et al. Down syndrome. Nat. Rev. Dis. Primers. 6, 9. https:\/\/doi.org\/10.1038\/s41572-019-0143-7 (2020).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"90469_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41419-018-0410-7","volume":"9","author":"D Fasano","year":"2018","unstructured":"Fasano, D. et al. Alteration of endosomal trafficking is associated with early-onset Parkinsonism caused by SYNJ1 mutations. Cell Death Dis. 9, 385. https:\/\/doi.org\/10.1038\/s41419-018-0410-7 (2018).","journal-title":"Cell Death Dis."},{"key":"90469_CR36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2353\/ajpath.2008.071053","volume":"173","author":"AM Cataldo","year":"2008","unstructured":"Cataldo, A. M. et al. Down syndrome fibroblast model of Alzheimer-related endosome pathology: Accelerated endocytosis promotes late endocytic defects. Am. J. Pathol. 173, 370\u2013384. https:\/\/doi.org\/10.2353\/ajpath.2008.071053 (2008).","journal-title":"Am. J. Pathol."},{"key":"90469_CR37","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1091\/mbc.e04-08-0735","volume":"16","author":"ES Ward","year":"2005","unstructured":"Ward, E. S. et al. From sorting endosomes to exocytosis: Association of Rab4 and Rab11 GTPases with the Fc receptor, FcRn, during recycling. Mol. Biol. Cell 16, 2028\u20132038. https:\/\/doi.org\/10.1091\/mbc.e04-08-0735 (2005).","journal-title":"Mol. Biol. Cell"},{"key":"90469_CR38","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1242\/jcs.116327","volume":"126","author":"Z Gan","year":"2013","unstructured":"Gan, Z., Ram, S., Ober, R. J. & Ward, E. S. Using multifocal plane microscopy to reveal novel trafficking processes in the recycling pathway. J. Cell Sci. 126, 1176\u20131188. https:\/\/doi.org\/10.1242\/jcs.116327 (2013).","journal-title":"J. Cell Sci."},{"key":"90469_CR39","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.216499","author":"N Naslavsky","year":"2018","unstructured":"Naslavsky, N. & Caplan, S. The enigmatic endosome\u2014Sorting the ins and outs of endocytic trafficking. J. Cell Sci. https:\/\/doi.org\/10.1242\/jcs.216499 (2018).","journal-title":"J. Cell Sci."},{"key":"90469_CR40","doi-asserted-by":"publisher","first-page":"e0182695","DOI":"10.1371\/journal.pone.0182695","volume":"12","author":"L D'Hooghe","year":"2017","unstructured":"D\u2019Hooghe, L., Chalmers, A. D., Heywood, S. & Whitley, P. Cell surface dynamics and cellular distribution of endogenous FcRn. PLoS ONE 12, e0182695. https:\/\/doi.org\/10.1371\/journal.pone.0182695 (2017).","journal-title":"PLoS ONE"},{"key":"90469_CR41","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1600-0854.2009.00887.x","volume":"10","author":"Z Gan","year":"2009","unstructured":"Gan, Z., Ram, S., Vaccaro, C., Ober, R. J. & Ward, E. S. Analyses of the recycling receptor, FcRn, in live cells reveal novel pathways for lysosomal delivery. Traffic 10, 600\u2013614. https:\/\/doi.org\/10.1111\/j.1600-0854.2009.00887.x (2009).","journal-title":"Traffic"},{"key":"90469_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo, A. M. et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: Differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157, 277\u2013286. https:\/\/doi.org\/10.1016\/s0002-9440(10)64538-5 (2000).","journal-title":"Am. J. Pathol."},{"key":"90469_CR43","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1093\/hmg\/dds142","volume":"21","author":"JC Cossec","year":"2012","unstructured":"Cossec, J. C. et al. Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes. Hum. Mol. Genet. 21, 3156\u20133172. https:\/\/doi.org\/10.1093\/hmg\/dds142 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"90469_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40478-020-00956-z","volume":"8","author":"A Botte","year":"2020","unstructured":"Botte, A. et al. Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome. Acta Neuropathol. Commun. 8, 89. https:\/\/doi.org\/10.1186\/s40478-020-00956-z (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"90469_CR45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tins.2017.08.003","volume":"40","author":"SA Small","year":"2017","unstructured":"Small, S. A., Simoes-Spassov, S., Mayeux, R. & Petsko, G. A. Endosomal traffic jams represent a pathogenic hub and therapeutic target in Alzheimer\u2019s disease. Trends Neurosci. 40, 592\u2013602. https:\/\/doi.org\/10.1016\/j.tins.2017.08.003 (2017).","journal-title":"Trends Neurosci."},{"key":"90469_CR46","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1083\/jcb.201711083","volume":"217","author":"XT Cheng","year":"2018","unstructured":"Cheng, X. T. et al. Characterization of LAMP1-labeled nondegradative lysosomal and endocytic compartments in neurons. J. Cell Biol. 217, 3127\u20133139. https:\/\/doi.org\/10.1083\/jcb.201711083 (2018).","journal-title":"J. Cell Biol."},{"key":"90469_CR47","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/biof.184","volume":"37","author":"L Tiano","year":"2011","unstructured":"Tiano, L. & Busciglio, J. Mitochondrial dysfunction and Down\u2019s syndrome: Is there a role for coenzyme Q(10)\u202f?. BioFactors 37, 386\u2013392. https:\/\/doi.org\/10.1002\/biof.184 (2011).","journal-title":"BioFactors"},{"key":"90469_CR48","doi-asserted-by":"publisher","first-page":"104268","DOI":"10.1016\/j.yexmp.2019.104268","volume":"110","author":"A Quinones-Lombrana","year":"2019","unstructured":"Quinones-Lombrana, A. & Blanco, J. G. Comparative analysis of the DYRK1A-SRSF6-TNNT2 pathway in myocardial tissue from individuals with and without Down syndrome. Exp. Mol. Pathol. 110, 104268. https:\/\/doi.org\/10.1016\/j.yexmp.2019.104268 (2019).","journal-title":"Exp. Mol. Pathol."},{"key":"90469_CR49","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1523\/JNEUROSCI.0578-19.2019","volume":"39","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y. et al. Lysosomal dysfunction in Down syndrome Is APP-Dependent and mediated by APP-betaCTF (C99). J. Neurosci. 39, 5255\u20135268. https:\/\/doi.org\/10.1523\/JNEUROSCI.0578-19.2019 (2019).","journal-title":"J. Neurosci."},{"key":"90469_CR50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrm2755","volume":"10","author":"BD Grant","year":"2009","unstructured":"Grant, B. D. & Donaldson, J. G. Pathways and mechanisms of endocytic recycling. Nat. Rev. Mol. Cell Biol. 10, 597\u2013608. https:\/\/doi.org\/10.1038\/nrm2755 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"90469_CR51","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1038\/s41467-018-06114-3","volume":"9","author":"IJ McGough","year":"2018","unstructured":"McGough, I. J. et al. SNX3-retromer requires an evolutionary conserved MON2:DOPEY2:ATP9A complex to mediate Wntless sorting and Wnt secretion. Nat. Commun. 9, 3737. https:\/\/doi.org\/10.1038\/s41467-018-06114-3 (2018).","journal-title":"Nat. Commun."},{"key":"90469_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ana.25752","volume":"88","author":"ME Curtis","year":"2020","unstructured":"Curtis, M. E., Yu, D. & Pratico, D. Dysregulation of the retromer complex system in Down syndrome. Ann. Neurol. 88, 137\u2013147. https:\/\/doi.org\/10.1002\/ana.25752 (2020).","journal-title":"Ann. Neurol."},{"key":"90469_CR53","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1371\/journal.pgen.0020050","volume":"2","author":"RJ Roper","year":"2006","unstructured":"Roper, R. J. & Reeves, R. H. Understanding the basis for Down syndrome phenotypes. PLoS Genet. 2, e50. https:\/\/doi.org\/10.1371\/journal.pgen.0020050 (2006).","journal-title":"PLoS Genet."},{"key":"90469_CR54","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0322-19.2020","author":"R Opsomer","year":"2020","unstructured":"Opsomer, R. et al. Amyloid precursor protein (APP) controls the expression of the transcriptional activator neuronal PAS domain protein 4 (NPAS4) and synaptic GABA release. eNeuro https:\/\/doi.org\/10.1523\/ENEURO.0322-19.2020 (2020).","journal-title":"eNeuro"},{"key":"90469_CR55","doi-asserted-by":"publisher","first-page":"26039","DOI":"10.1074\/jbc.M113.461269","volume":"288","author":"DA Hicks","year":"2013","unstructured":"Hicks, D. A. et al. The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines. J. Biol. Chem. 288, 26039\u201326051. https:\/\/doi.org\/10.1074\/jbc.M113.461269 (2013).","journal-title":"J. Biol. Chem."},{"key":"90469_CR56","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1242\/jcs.01323","volume":"117","author":"RC von Rotz","year":"2004","unstructured":"von Rotz, R. C. et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 117, 4435\u20134448. https:\/\/doi.org\/10.1242\/jcs.01323 (2004).","journal-title":"J. Cell Sci."},{"key":"90469_CR57","doi-asserted-by":"publisher","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass, C., Kaether, C., Thinakaran, G. & Sisodia, S. Trafficking and proteolytic processing of APP. Cold Spring Harb. Perspect. Med. 2, a006270. https:\/\/doi.org\/10.1101\/cshperspect.a006270 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"90469_CR58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pneurobio.2008.05.002","volume":"85","author":"T Muller","year":"2008","unstructured":"Muller, T., Meyer, H. E., Egensperger, R. & Marcus, K. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer\u2019s disease. Prog. Neurobiol. 85, 393\u2013406. https:\/\/doi.org\/10.1016\/j.pneurobio.2008.05.002 (2008).","journal-title":"Prog. Neurobiol."},{"key":"90469_CR59","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.yexcr.2008.05.003","volume":"314","author":"E Waldron","year":"2008","unstructured":"Waldron, E. et al. Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription. Exp. Cell Res. 314, 2419\u20132433. https:\/\/doi.org\/10.1016\/j.yexcr.2008.05.003 (2008).","journal-title":"Exp. Cell Res."},{"key":"90469_CR60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1126\/science.1058783","volume":"293","author":"X Cao","year":"2001","unstructured":"Cao, X. & Sudhof, T. C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115\u2013120. https:\/\/doi.org\/10.1126\/science.1058783 (2001).","journal-title":"Science"},{"key":"90469_CR61","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1038\/s41598-019-45203-1","volume":"9","author":"RB Cejas","year":"2019","unstructured":"Cejas, R. B., Ferguson, D. C., Quinones-Lombrana, A., Bard, J. E. & Blanco, J. G. Contribution of DNA methylation to the expression of FCGRT in human liver and myocardium. Sci. Rep. 9, 8674. https:\/\/doi.org\/10.1038\/s41598-019-45203-1 (2019).","journal-title":"Sci. Rep."},{"key":"90469_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11095-017-2294-0","volume":"35","author":"DC Ferguson","year":"2018","unstructured":"Ferguson, D. C. & Blanco, J. G. Regulation of the human Fc-neonatal receptor alpha-chain gene FCGRT by microRNA-3181. Pharm. Res. 35, 15. https:\/\/doi.org\/10.1007\/s11095-017-2294-0 (2018).","journal-title":"Pharm. Res."},{"key":"90469_CR63","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3389\/fimmu.2020.00840","volume":"11","author":"Y Dieudonne","year":"2020","unstructured":"Dieudonne, Y. et al. Immune defect in adults with down syndrome: Insights into a complex issue. Front. Immunol. 11, 840. https:\/\/doi.org\/10.3389\/fimmu.2020.00840 (2020).","journal-title":"Front. Immunol."},{"key":"90469_CR64","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.xcrm.2020.100019","volume":"1","author":"JM Espinosa","year":"2020","unstructured":"Espinosa, J. M. Down syndrome and COVID-19: A perfect storm?. Cell Rep. Med. 1, 100019. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100019 (2020).","journal-title":"Cell Rep. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90469-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90469-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90469-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:49:39Z","timestamp":1670039379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90469-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90469"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90469-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.15.422747","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10981"}}